Can you assure us and through us, the American people, that that will not be the case as these other services are provided moving forward?

I am concerned that this could become the model for other such mergers, and we would lose the engine for innovation and growth here in the United States.

Companies like Allergan invest significant capital in R&D in order to continue to development treatments for unmet medical needs.

Given this situation, I would be interested in the panel's view as to whether Federal legislation is needed.

Earlier this week, a bill on which I had worked with Congresswoman Matsui of this committee, the Excellence in Mental Health Act, was included in a larger piece of legislation, and I am pleased that the President has signed that into law.

I hope that these fine efforts can continue and that we can work in a bipartisan capacity on this very important issue.

I want to work to the greatest extent possible to allay the concerns of the constituents whom I represent.

I support Mr. Shimkus' legislation.

I do support his legislation, and I would hope that the Administration might work in a cordial fashion with Mr. Shimkus as the situation moves forward.

I want to reiterate the concerns of my constituents, and I would like to work in a fashion where we are effective to make sure that this be as open a process as possible.

the safety and health of the American people is preeminent.